Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Hope Rugo

Breast Oncology · City of Hope

View

Dr. Virginia Borges

Breast Oncology · CU Anschutz Medical Campus

View

Dr. William Gradishar

Breast Oncology · NU

View

Dr. Jame Abraham

Breast Oncology · Cleveland Clinic

View

Dr. Azka Ali

Breast Oncology · Cleveland Clinic Lerner

View

Dr. Amy Comander

Breast Oncology · PHS

View

Dr. Paolo Tarantino

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Anastasia Martynova

Breast Oncology · USC

View

Dr. Rani Bansal

Breast Oncology · Duke

View

Dr. Gilbert Bader

Breast Oncology · OSUMC

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    CDDr. Charles Dai

    Dr. Charles Dai

    Hematology & Oncology · Breast Oncology
    Massachusetts General Hospital
    charlesd

    Research

    Epitope Expression Persists in Circulating Tumor Cells as Breast Cancers Acquire Resistance to Antibody Drug Conjugates

    2025

    Via bioRxiv (Preprint)

    Research

    Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes

    2025

    Via Breast Cancer Research and Treatment

    Research

    Circulating tumor cells: Blood-based detection, molecular biology, and clinical applications

    2025

    Via Cancer Cell

    Research

    Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR+/HER2- metastatic breast cancer: a retrospective multi-institutional Consortium analysis

    2025

    Via NPJ Breast Cancer

    Research

    Novel oral selective estrogen receptor degraders (SERDs) to target hormone receptor positive breast cancer: elacestrant as the poster-child

    2024

    Via Expert Review of Anticancer Therapy

    Research

    Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling

    2024

    Via Cancer Letters

    Research

    TRK inhibitor in a patient with metastatic triple-negative breast cancer and fusions identified by cell-free DNA analysis

    2023

    Via Therapeutic Advances in Medical Oncology

    Research

    Revisiting Androgen Receptor Signaling in Breast Cancer

    2023

    Via The Oncologist

    Research

    Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis

    2023

    Via JCO Precision Oncology

    Research

    Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer

    2023

    Via Clinical Cancer Research

    Research

    Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis

    2023

    Via Breast Cancer Research

    Research

    Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer

    2022

    Via EBioMedicine